Accueil > Actualité
Actualite financiere : Actualite bourse

Gimv: invests in Belgian biotech firm

( - Belgian investment company Gimv is investing 6 million euros in Belgian biotech firm Camel-IDS, the group said in a statement on Thursday.

This transaction is part of the latest financing round obtained by Camel-IDS, a Brussels-based company developing cancer-targeted radiopharmaceuticals, whereby the company secured funding of 37 million euros.

This financing will enable Camel-IDS to run a phase Ib/II trial with its lead program targeting brain metastatic breast cancer, Gimv said.

Copyright (c) 2018 All rights reserved.




Qui sommes-nous ? | Nous contacter | FAQ | Mentions légales | RSS | © Copyright 2007 Cercle Finance. Tous droits réservés.
Indices et cours différés d’au moins 15 mn | Cotations boursières fournies par ABC Bourse.